Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.
Funding of PBTCF 2020: PBTC-058 - $25,000
$25,000.00
January 2020
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
Sydney Children's Hospital - $151,468
$151,468.00
December 2019
Developing New Epigenetic Combination Treatments Against DIPG.
Oncoceutics ONC201 - $100,000
$100,000.00
December 2019
Expansion of the ONC201 Compassionate Use.
University of Sydney - $100,000
$100,000.00
November 2019
Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.
University of Michigan Hospitals - $157,856
$157,856.00
November 2019
Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG
Dayton Children's Hospital - $69,600
$69,600.00
November 2019
Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.
Institute of Cancer Research - $121,863
$121,863.00
November 2019
Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.
Bambino Gesu Children's Hospital - $49,803
$49,803.00
August 2019
Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.
Telethon Kids Institute - $49,512
$49,512.00
August 2019
Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.
Oncoceutics ONC201 - Phase II - $83,333
$83,333.00
May 2019
Expansion of the ONC201 Compassionate Use.
Funding of PBTCF 2019: PBTC-058 - $25,000
$25,000.00
January 2019
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
Sydney Children’s Hospital - $175,089
$175,089.00
November 2018
Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital - $540,742
$540,742.00
November 2018
Expansion of the International DIPG Registry.
Bambino Gesú Children's Hospital - $99,382
$99,382.00
November 2018
Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.
Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000
$35,000.00
November 2018
Credentialing an Improved DIPG Mouse Model.